Cargando…
The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
Alzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the cons...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249562/ https://www.ncbi.nlm.nih.gov/pubmed/34222342 http://dx.doi.org/10.3389/fmolb.2021.697913 |
_version_ | 1783716921824247808 |
---|---|
author | Dekker, Françoise A. Rüdiger, Stefan G. D. |
author_facet | Dekker, Françoise A. Rüdiger, Stefan G. D. |
author_sort | Dekker, Françoise A. |
collection | PubMed |
description | Alzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the conserved Hsp90 chaperone class, tumour necrosis factor receptor-associated protein 1 (TRAP1), is strongly downregulated in AD, more than other major PQC factors. Here, we review molecular mechanism and cellular function of TRAP1 and subsequently discuss possible links to AD. TRAP1 is an interesting paradigm for the Hsp90 family, as it chaperones proteins with vital cellular function, despite not being regulated by any of the co-chaperones that drive its cytosolic paralogues. TRAP1 encloses late folding intermediates in a non-active state. Thereby, it is involved in the assembly of the electron transport chain, and it favours the switch from oxidative phosphorylation to glycolysis. Another key function is that it ensures mitochondrial integrity by regulating the mitochondrial pore opening through Cyclophilin D. While it is still unclear whether TRAP1 itself is a driver or a passenger in AD, it might be a guide to identify key factors initiating neurodegeneration. |
format | Online Article Text |
id | pubmed-8249562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82495622021-07-03 The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease Dekker, Françoise A. Rüdiger, Stefan G. D. Front Mol Biosci Molecular Biosciences Alzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the conserved Hsp90 chaperone class, tumour necrosis factor receptor-associated protein 1 (TRAP1), is strongly downregulated in AD, more than other major PQC factors. Here, we review molecular mechanism and cellular function of TRAP1 and subsequently discuss possible links to AD. TRAP1 is an interesting paradigm for the Hsp90 family, as it chaperones proteins with vital cellular function, despite not being regulated by any of the co-chaperones that drive its cytosolic paralogues. TRAP1 encloses late folding intermediates in a non-active state. Thereby, it is involved in the assembly of the electron transport chain, and it favours the switch from oxidative phosphorylation to glycolysis. Another key function is that it ensures mitochondrial integrity by regulating the mitochondrial pore opening through Cyclophilin D. While it is still unclear whether TRAP1 itself is a driver or a passenger in AD, it might be a guide to identify key factors initiating neurodegeneration. Frontiers Media S.A. 2021-06-18 /pmc/articles/PMC8249562/ /pubmed/34222342 http://dx.doi.org/10.3389/fmolb.2021.697913 Text en Copyright © 2021 Dekker and Rüdiger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Dekker, Françoise A. Rüdiger, Stefan G. D. The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease |
title | The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease |
title_full | The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease |
title_fullStr | The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease |
title_full_unstemmed | The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease |
title_short | The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease |
title_sort | mitochondrial hsp90 trap1 and alzheimer’s disease |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249562/ https://www.ncbi.nlm.nih.gov/pubmed/34222342 http://dx.doi.org/10.3389/fmolb.2021.697913 |
work_keys_str_mv | AT dekkerfrancoisea themitochondrialhsp90trap1andalzheimersdisease AT rudigerstefangd themitochondrialhsp90trap1andalzheimersdisease AT dekkerfrancoisea mitochondrialhsp90trap1andalzheimersdisease AT rudigerstefangd mitochondrialhsp90trap1andalzheimersdisease |